期刊文献+

昆虫细胞偏爱密码子优化的HPV16L1基因在昆虫和哺乳动物细胞中的表达 被引量:5

The optimization of human papillomavirus type 16 L1 gene following the insect cell condon bias can achieve effective expression in both insect and mammalian cells
暂未订购
导出
摘要 目的获得有效表达人乳头瘤病毒16型(HPV16)L1基因的重组杆状病毒和腺病毒,为研究HPV的免疫保护机制提供材料。方法按照昆虫细胞密码子偏爱优化并合成HPV16L1基因,利用Bac-to-Bac昆虫表达系统获得表达HPV16L1基因的重组杆状病毒,利用AdEasy腺病毒载体系统获得表达HPV16L1基因的重组腺病毒载体。通过间接免疫荧光和Western blot对HPV16L1基因表达进行鉴定,利用负染电子显微镜观察病毒样颗粒(VLP)的形成。结果获得了稳定表达HPV16L1蛋白的重组杆状病毒和重组腺病毒载体,在Sf9细胞和293细胞中可有效表达能被抗HPV16L1单克隆抗体识别的L1蛋白,分子质量单位为56ku,在Sf9细胞中可观察到VLP的形成。结论按照昆虫细胞密码子偏爱进行优化的HPV16L1基因,在昆虫细胞和哺乳动物细胞内均可有效表达。 Objective To generate recombinant baculovirus and adenovirus which can express human papillomavirus type 16 (HPV16) L1 gene to provide materials for investigating the immunological mechanisms of HPV infection. Methods The HPV16L1 gene was artificially synthesized after optimization following insect cell codon bias. The recombinant baculovirus and adenovirus harboring the HPV16L1 were generated through Bac-to-Bac Baculovirus Expression System and AdEasy Adenoviral Vector System, respectively. The expression of the HPV16L1 was confirmed by both indirect immunofluorescence and Western blot. The virus-like particles (VLPs) of HPV16 was identified by negative staining electron microscopy. Results Both the recombinant baculovirus and adenovirus bearing HPV16L1 were successfully generated. The effective expression of HPV16L1 in insect Sf9 cells or 293 cells were detected by the monoclonal antibody which is specific to HPV16 L1, respectively, and the assembly of VLPs was observed in Sf9 cells. Conclusion The HPV16L1 gene optimized according to insect cell condon bias can be expressed effectively in both insect and mammalion cells.
出处 《中国病原生物学杂志》 CSCD 2007年第4期247-251,共5页 Journal of Pathogen Biology
关键词 人乳头瘤病毒u 16型 重组腺病毒 重组杆状病毒 表达 密码子优化 病毒样颗粒 Human papillomavirus type 16 L1 recombinant adenovirus recombinant baculovirus expression codonoptimization virus-like particle (VLP)
  • 相关文献

参考文献17

  • 1Trottier H,Franco EL.The epidemiology of genital human papillomavirus infection[J].Vaccine,2006,30;24 Suppl 1:S1-15.
  • 2Seheurer ME,Tortolero-Luna G,Adler-Storthz K.Human papillomavirus infection:biology,epidemiology,and prevention[J].Int J Gynecol Cancer,2005,15(5):727-746.
  • 3Harper DM,Franco EL,Wheeler CM,et al.Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18:follow-up from a randomised control trial[J].Lancet,2006,367(9518):1247-1255.
  • 4Mao C,Koutsky LA,Ault KA,et al.Efficacy of human papillomavirus 16 vaccine to prevent cervical intraepithelial neoplasia:a randomized controlled trial[J].Obstet Gynecol,2006,107(1):18-27.
  • 5Villa LL,Costa RL,Petta CA,et al.High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18L1 virus-like particle vaccine through 5 years of follow-up[J].Br J Cancer,2006,95(11):1459-1466.
  • 6Rudin A,Johansson EL,Bergquist C,et al.Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans[J].Infect Immun,1998,66(7):3390-3396.
  • 7Bangari DS,Mittal SK.Development of nonhuman adenoviruses as vaccine vectors[J].Vaccine,2006,24(7):849-862.
  • 8Tatsis N,Ertl HC.Adenoviruses as vaccine vectors[J].Mol Ther,2004,10(4):616-629.
  • 9Zhou J,Liu WJ,Peng SW,et al.Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability[J].J Virol,1999,73(6):4972-4982.
  • 10周玉柏,周玲,吴小兵,曾毅.腺病毒载体介导密码子优化型HPV 16 L1基因在哺乳动物细胞中的高效表达及病毒样颗粒的装配[J].病毒学报,2006,22(2):101-106. 被引量:3

二级参考文献16

  • 1Clifford G M,Smith J S,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[J].Br J Cancer,2003 ,88:63-73.
  • 2Bosch F X,Manos M M,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective[J].J Natl Cancer Inst ,1995 ,87:796-802.
  • 3Harro C D,Pang Y Y,Roden R B,et al.Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine[J].J Natl Cancer Inst ,2001 ,93:284-292.
  • 4Brown D R,Bryan J T,Schroeder J M,et al.Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles:correlation with competitive radioimmunoassay titer[J].J Infect Dis ,2001,184:1183-1186.
  • 5Koutsky L A,Ault K A,Wheeler C M,et al.A controlled trial of a human papillomavirus type 16 vaccine[J].N Engl J Med ,2002 ,347:1645-1651.
  • 6Lehner T,Wang Y,Cranage M,et al.Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques[J].Nat Med ,1996,2:767-775.
  • 7Xiang Z Q,Pasquini S,Ertl H C J.Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant[J].J Immunol,1999,162:6716-6723.
  • 8McConnell M J ,Imperiale M J.Biology of adenovirus and its use as a vector for gene therapy[J].Human Gene Therapy ,2004,15 (11):1022-1033.
  • 9Nakamura Y,Gojobori T,Ikemura T.Codon usage tabulated from international DNA sequence databases:status for the year 2000[J].Nucleic Acids Res ,2000,28:292.
  • 10Pyeon D,Lambert P F,Ahlquist P .Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation[J].Proc Natl Acad Sci USA,2005,102:9311-9316.

共引文献2

同被引文献58

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部